Pharmacia & Upjohn Inc Sample Contracts

EXHIBIT H ===================================================================== =========== CREDIT AGREEMENT
Credit Agreement • March 1st, 1999 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
JOINT FILING AGREEMENT
Joint Filing Agreement • April 10th, 2000 • Pharmacia & Upjohn Inc • Pharmaceutical preparations
JOINT FILING AGREEMENT ----------------------
Joint Filing Agreement • March 1st, 1999 • Pharmacia & Upjohn Inc • Pharmaceutical preparations

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of Miravant Medical Technologies, and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.

EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER DATED AS OF DECEMBER 19, 1999
Agreement and Plan of Merger • December 29th, 1999 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • Delaware
as Trustee 2 CERTAIN SECTIONS OF THIS INDENTURE RELATING TO SECTIONS 310 THROUGH 318, INCLUSIVE, OF THE TRUST INDENTURE ACT OF 1939:
Indenture • July 13th, 1999 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • New York
1 PHARMACIA & UPJOHN, INC. COMMON STOCK, $.01 PAR VALUE UNDERWRITING AGREEMENT
Pharmacia & Upjohn Inc • January 12th, 1999 • Pharmaceutical preparations • New York
JOINT FILING AGREEMENT
Joint Filing Agreement • December 2nd, 1998 • Pharmacia & Upjohn Inc • Pharmaceutical preparations
JOINT FILING STATEMENT
Joint Filing Statement • April 10th, 2000 • Pharmacia & Upjohn Inc • Pharmaceutical preparations
STOCKHOLDER PROTECTION RIGHTS AGREEMENT
Stockholder Protection Rights Agreement • March 5th, 1997 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • Delaware
Project Phosphate Term Sheet
Pharmacia & Upjohn Inc • December 2nd, 1998 • Pharmaceutical preparations
CONTRACT MODIFICATION AND TERMINATION AGREEMENT
Contract Modification and Termination Agreement • March 15th, 2002 • Pharmacia & Upjohn Inc • Pharmaceutical preparations • New York

The foregoing opinion is limited to the Federal laws of the United States and the laws of the State of New York, and we are expressing no opinion as to the effect of the laws of any other jurisdiction.

AMENDMENT TO THE UPJOHN MANAGEMENT INCENTIVE PROGRAM OF 1992
Pharmacia & Upjohn Inc • November 2nd, 1995 • Pharmaceutical preparations
AutoNDA by SimpleDocs
JOINT FILING STATEMENT
Joint Filing Statement • March 15th, 2002 • Pharmacia & Upjohn Inc • Pharmaceutical preparations

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of Miravant Medical Technologies, and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.

Time is Money Join Law Insider Premium to draft better contracts faster.